NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG

about

Autophagy: In the cROSshairs of cancer.A tool for discovering drug sensitivity and gene expression associations in cancer cells.Carnosic acid, an inducer of NAD(P)H quinone oxidoreductase 1, enhances the cytotoxicity of β-lapachone in melanoma cell lines.

P2860

Q34543548-E5797334-DFAF-400C-B25E-CA952AEFFBB8 Q36358010-985A2BDD-656F-4ED5-9B9C-D431B32F8805 Q50053547-29340562-99BA-45E7-9924-B788953E6378

P2860

NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG

Item

http://www.wikidata.org/entity/Q35979667

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

NAD(P)H:Quinone Oxidoreductase ...... to the HSP90 Inhibitor 17-AAG

@ast

NAD(P)H:Quinone Oxidoreductase ...... to the HSP90 Inhibitor 17-AAG

@en

type

Item

label

NAD(P)H:Quinone Oxidoreductase ...... to the HSP90 Inhibitor 17-AAG

@ast

NAD(P)H:Quinone Oxidoreductase ...... to the HSP90 Inhibitor 17-AAG

@en

prefLabel

NAD(P)H:Quinone Oxidoreductase ...... to the HSP90 Inhibitor 17-AAG

@ast

NAD(P)H:Quinone Oxidoreductase ...... to the HSP90 Inhibitor 17-AAG

@en

P1476

NAD(P)H:Quinone Oxidoreductase ...... to the HSP90 Inhibitor 17-AAG

@en

P2093

Ayaka Okubo

http://www.w3.org/2001/XMLSchema#string

Chihaya Maesawa

http://www.w3.org/2001/XMLSchema#string

Masahiko Shibazaki

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Arakawa

http://www.w3.org/2001/XMLSchema#string

Shinji Yasuhira

http://www.w3.org/2001/XMLSchema#string

Shuya Kasai

http://www.w3.org/2001/XMLSchema#string

Tomoyuki Masuda

http://www.w3.org/2001/XMLSchema#string

Toshihide Akasaka

http://www.w3.org/2001/XMLSchema#string

Wataru Shigeeda

http://www.w3.org/2001/XMLSchema#string

P2860

NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones

Local melatoninergic system as the protector of skin integrity

BRAF and NRAS mutations in melanoma: potential relationships to clinical response to HSP90 inhibitors.

Melanin pigmentation in mammalian skin and its hormonal regulation

The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene?

Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer

Drug combination studies and their synergy quantification using the Chou-Talalay method

Impact of NAD(P)H:quinone oxidoreductase-1 on pigmentation.

Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.

Safety, efficacy, pharmacokinetics, and pharmacodynamics of the combination of sorafenib and tanespimycin

P304

e0153181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0153181

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27045471

http://www.w3.org/2001/XMLSchema#string

P921

tanespimycin

P932

4821458

http://www.w3.org/2001/XMLSchema#string

NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG

about

P2860

P2860

NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932